Abstract
Ixekizumab (Taltz (R)) is a subcutaneously administered, humanized anti-interleukin-17A monoclonal antibody indicated for the treatment of adults with......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
